Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

GSK plc (GSK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,458.20 -25.40    -1.71%
16:29:53 - Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 620,124
  • Bid/Ask: 17.18 / 17.26
  • Day's Range: 1,455.70 - 1,481.40
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BN7SWP63 
SEDOL:  BN7SWP6
GSK plc 1,458.20 -25.40 -1.71%

GSK Financial Summary

 
See below for an overview of the Glaxo financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

GSK plc reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was GBP 7,829 million compared to GBP 6,627 million a year ago. Net income was GBP 10,315 million compared to GBP 1,168 million a year ago. Basic earnings per share from continuing operations was GBP 0.188 compared to GBP 0.219 a year ago. Diluted earnings per share from continuing operations was GBP 0.186 compared to GBP 0.216 a year ago. Basic earnings per share was GBP 2.559 compared to GBP 0.292 a year ago. Diluted earnings per share was GBP 2.523 compared to GBP 0.288 a year ago.For the nine months, sales was GBP 21,948 million compared to GBP 17,620 million a year ago. Net income was GBP 12,955 million compared to GBP 3,636 million a year ago. Basic earnings per share from continuing operations was GBP 0.736 compared to GBP 0.722 a year ago. Diluted earnings per share from continuing operations was GBP 0.725 compared to GBP 0.714 a year ago. Basic earnings per share was GBP 3.22 compared to GBP 0.908 a year ago. Diluted earnings per share was GBP 3.173 compared to GBP 0.898 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GSK Income Statement

Gross margin TTM 65.13%
Operating margin TTM 24.19%
Net Profit margin TTM 35.65%
Return on Investment TTM 19.75%
 Total Revenue  Net Income
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Revenue 7829 6929 7190
Gross Profit 4784 4500
Operating Income 1709 1708
Net Income 10315 838 1802

GSK Balance Sheet

Quick Ratio MRQ 0.7
Current Ratio MRQ 0.97
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 241.65%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Total Assets 60313 89045 89689 79103
Total Liabilities 51597 66405 67057 57761
Total Equity 8716 22640 22632 21342

GSK Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  6.30%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1321 2542
Cash From Investing Activities -4094 -3593
Cash From Financing Activities -1326 7973
Net Change in Cash -4076 6934
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GSK Comments

Write your thoughts about GSK plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dan Morris
Dan Morris Dec 07, 2022 13:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lovely little boost from the Zantec case today. Let's hope the shares kick onwards from here
איציק צארלי
איציק צארלי Nov 28, 2022 16:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ITH stock
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought back all the gsk that I sold back in May. It's a no brainer at this price
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying GSK is like investing in a junk bond. One need to buy when the yield is high
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
. Well, yield is OK as long as it's not offset by value destruction through capital loss. In GSKs case as long as Walmsley is at the helm you can guarantee value destruction. She couldn't develop a blockbuster drug or vaccine if her life depended on it. Pascal Sorrel at Astra Zenrcca must be laughing his head off at this train crash of a CEO
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You are right. Also the price has been range bound for a decade and we are now near to the lower bound. I've heard similar comments to you nearly ever year when it's price is underperforming
Mike Bamber
Mike Bamber Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wish the institutional shareholders would wake up and do something about the management team. Surely with such an abysmal performance over so long GSK must be a takeover target?
Anon Anon
Anon Anon Nov 11, 2022 16:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm only interested in swing trading this counter. If the price doesn't move I'll just collect dividends while waiting for it to bounce. The spinoff of Haleon is a good move as in this day and age companies need to be pure play to get ahead of competition. Consumer healthcare business was a distraction to their management.
John Hamilton
John Hamilton Nov 11, 2022 12:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
new management required
John Williams
John Williams Sep 08, 2022 14:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bloodbath coming
Ozkan Gokmenoglu
Ozkan Gokmenoglu Sep 08, 2022 14:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hi John, it will be worsth ?
Alun Benjamin
Alun Benjamin Sep 08, 2022 14:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When will this carnage start, exacty (02/11/22)
Jenny Gough
Jenny Gough Aug 11, 2022 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Should have taken the Unilever offer...
Mark Olive
magicpiano Aug 11, 2022 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It was madness not to.
Mike Bamber
Mike Bamber Jul 18, 2022 16:06
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Demerger yet another damp squib in a long line of failures by Walmsley. She is unprecedented in her ability to talk the talk but to not walk the walk!
Anon Anon
Anon Anon Jan 17, 2022 11:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
Anon Anon
Anon Anon Dec 09, 2021 8:46
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
Will Strath
Will Strath Nov 05, 2021 12:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ex-div in 13 days time. why risk selling now when you might not get back on the boat? pretty sure the company split will reach equivalent of 2000+ for the two new companies.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email